Company / CapEx per Share
Arrowhead Pharmaceuticals CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.18
FY2025
5-year range
$0.11 / $1.32
FY2021-FY2025
Trend
-86.2%
vs FY2024
Sector context
#45 of 192
Health Care
What the data says
Arrowhead Pharmaceuticals's capex per share of $0.18 is higher than 77% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2017 to $1.32 in FY2024.
Based on SEC 10-K filings.
0.18 in FY2025 with a 5-year CAGR of +7.8%. Top quartile in the Health Care sector.
Declined from $0.22 to $0.18 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +16.7%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
-94.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 86.2% year-over-year.
- Ranks #45 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.18 | -86.2% |
| FY2024 | $1.32 | +492.7% |
| FY2023 | $0.22 | +94.1% |
| FY2022 | $0.11 | -50.2% |
| FY2021 | $0.23 | +83.9% |
| FY2020 | $0.13 | +39.9% |
| FY2019 | $0.09 | +73.3% |
| FY2018 | $0.05 | +82.7% |
| FY2017 | $0.03 | -56.4% |
| FY2016 | $0.06 | +1093.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026